Investor Relations
Investor Overview
Targeted Medical Pharma Inc. is a pioneer in the development of physician prescribed therapeutic systems for the nutritional management of chronic diseases. The company strives to improve patient care with safe and clinically effective prescription medical food products, generic drugs and branded drugs and convenience kits. Physician Therapeutics, a division of the company, manufactures and distributes these proprietary medical food products through a network of distributors and sales representatives to physicians and select pharmacies throughout the United States .
Complete Claims Processing Inc. (CCPI) is a wholly owned subsidiary of Targeted Medical Pharma Inc. CCPI provides billing and collection services on behalf of dispensing physician clients for workers compensation, private insurance and Medicare claims.
Laboratory Industry Services is a division of Targeted Medical Pharma Inc. and is certified by CMS Medicare as an "Independent Diagnostic Testing Facility" that performs the technical analysis of certain diagnostic procedures in both the clinical setting and as a Core Laboratory for research applications. Founded in 1996, this Company has developed proprietary software applications for measuring autonomic nervous system function and assessment of cardiac risk from drugs that prolong the QT interval and thereby increase the risk of cardiac arrhythmias leading to sudden death. These systems have been used in the development of TMP products to provide measurable physiological end points that ensure safety and efficacy. The company provides services to clinicians, the pharmaceutical industry and governmental entities in research trials.
We are committed to delivering long-term value to investors by maintaining disciplined cost controls, optimizing capital investment and adhering to the highest standards of corporate governance.
Recent News
Investor Relations Contact
Matthew Sheldon
PondelWilkinson Inc.
Email: msheldon@pondel.com
Phone: 310-279-5975